Doctors are regularly combining different cancer therapies, trying to find a magic bullet to cure cancer or at least extend survival by a few precious weeks or months. One drug in...
Read PostNew Cell Tracking for Understanding Tumor Resistance to Cancer Treatment
By: Devin Golden
September 23, 2021
Mesothelioma cells grow quite resistant to treatment. Therapies like chemotherapy and radiation therapy inhibit the cancer for a few months before their effectiveness...
Read Post3 Ways to Show Support on Mesothelioma Awareness Day
By: Alex Hall
September is mesothelioma awareness month, with the actual mesothelioma awareness day falling on Sunday, the 26th. If you know someone or if you have a loved one who has been...
Read PostMesothelioma Verdict for Plant Worker Backed Up in Appeals Court
By: Devin Golden
September 22, 2021
A South Carolina Court of Appeals backed a deceased plant worker’s mesothelioma compensation of nearly $3 million. The case, which ended with a $2.87 million verdict in 2017,...
Read PostThree-Year Survival Rate for Mesothelioma Up With Opdivo and Yervoy
By: Devin Golden
September 21, 2021
The three‑year survival rate for unresectable mesothelioma is up considerably when Opdivo and Yervoy are the treatment approach. It’s positive news for people believing in...
Read PostPeritoneal Mesothelioma Specialist Discusses Quality of Life for Patients
By: Devin Golden
September 16, 2021
Will it work? Maybe. Is it worth exploring? Sure. Is it at the point where it should be widely accepted? That’s another discussion. Dr. Edward Levine had a similar response to...
Read PostA new report gives gloomy data about the future and present health of firefighters on duty for the September 11 terrorist attacks. According to a report from the FDNY World Trade...
Read PostThe COVID‑19 pandemic has been a challenge for cancer patients. Many are anxious about going to a hospital for in‑person appointments. For some, such as people with thoracic...
Read PostData presented at the 2021 World Conference on Lung Cancer painted a bleak picture regarding mesothelioma and COVID-19 infection. The Vall d’Hebron University Hospital in...
Read PostCAR T‑cell therapy and immune checkpoint inhibitors seem to work together for malignant mesothelioma. A phase 1 clinical trial at Memorial Sloan Kettering Cancer Center ended...
Read Post